7-55366135-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018697.4(LANCL2):c.110C>A(p.Ala37Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000452 in 1,547,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018697.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LANCL2 | NM_018697.4 | c.110C>A | p.Ala37Glu | missense_variant | 1/9 | ENST00000254770.3 | NP_061167.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LANCL2 | ENST00000254770.3 | c.110C>A | p.Ala37Glu | missense_variant | 1/9 | 1 | NM_018697.4 | ENSP00000254770 | P1 | |
LANCL2 | ENST00000452107.6 | c.26C>A | p.Ala9Glu | missense_variant, NMD_transcript_variant | 1/10 | 5 | ENSP00000387598 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152252Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000183 AC: 3AN: 164186Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 88996
GnomAD4 exome AF: 0.00000358 AC: 5AN: 1395064Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 687406
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152252Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.110C>A (p.A37E) alteration is located in exon 1 (coding exon 1) of the LANCL2 gene. This alteration results from a C to A substitution at nucleotide position 110, causing the alanine (A) at amino acid position 37 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at